Sign up to save your podcasts
Or
Share Biobanking Trends
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biobanking Trends
Dr. K. Stephen Suh, a Precision Medicine Expert, based in the United States, participates in Risk Roundup to discuss BioBanking Trends.
Risk Roundup Webcast: Biobanking Trends
Biobanking Trends
Technology has now made it possible for broad sharing of information, rapid analysis, and automation of testing. Moreover, the whole genome data and digital sharing capability are improving the research capabilities. From artificial intelligence-driven process automation, genetic testing, genome analysis, digitization, robotics, data analytics to the internet, the rapidly emerging technological advances, are on their way to revolutionizing biobanks, biorepository, and biospecimen science.
While drug discovery and development seems to be the primary focus, biobank research hopes to provide a new understanding into the genetic component of the disease, that would ultimately lead to a more personalized and precise approach to healthcare. Moreover, the growing investments are enabling the scientific progress that will strongly influence our knowledge about human health and disease, the quality and nature of health care, and human life.
Understandably, biobanking
is rapidly becoming a key area for infrastructure development as there is a
rise in many kinds of biobanks. From disease-centric, population-based, genetic
or DNA/RNA, project-driven, tissue versus multiple specimen types, commercial
versus community-based, microbiome to stem cells, and virtual biobanks, there
are many types of biobanks emerging. As the ultimate aims of biobanks include
promoting the health and well-being of the community at no individual cost or
risk, the question is, how will that be possible.
Complex Challenges
Biobanks have triggered a robust debate about ethical, legal, and social implications surrounding human samples and data due to issues of consent, privacy, confidentiality, and integrity of the samples and the return of results and data-sharing. So, as we witness the evolution of biobanking from a simple collection of frozen specimens to the virtual biobanks and bioscience as seen today, it is essential to understand its risks and rewards-
- What are the challenges
of biobanking broadly?Do all nations have
biobanks and the technology necessary for them?How will personalized
medicine benefit from biobanking?Are there any
guidelines about biobanking? What are the best practices?How can biobanks balance
benefits and risks?Is there a need for
regulation?
As biobanking is on its way to changing the world, the time is now to discuss the risks and rewards of biobanking.
For more, please watch the Risk Roundup Webcast or hear the Risk Roundup Podcast
About
the Guest
Dr. K. Stephen Suh is a professional with a Doctor of Philosophy (Ph.D.) focused in Cell and Molecular Biology, Animal Modeling of Cancer, 3-Dimensional Cell Culture and Tissue Engineering, and the use of Artificial Intelligence System on Data Mining of Electronic Health Records and Biobank-Patient Samples. He is an expert for Precision Medicine topics and achieving the concept for Personalized Medicine and biomarker-based Population and Patient Selection for clinical testing platforms.
About the Host of Risk Roundup
Jayshree
Pandya (née Bhatt), the founder and chief executive officer of Risk Group LLC (www.riskgroupllc.com) is working
passionately to define a new security-centric operating system for humanity.
Her efforts towards building a strategic security risk analytics platform are
to equip the global strategic security community with the tools and culture to
collectively imagine the strategic security risks to our future and to define
and design a new security-centric operating system for the future of humanity.
About Risk Roundup
Risk Roundup, a global initiative
launched by Risk Group, is a security risk reporting for risks emerging from
existing and emerging technologies, technology convergence, and transformation
happening across cyberspace, aquaspace, geospace, and space. Risk Roundup is
released in both audio (Podcast) and video (Webcast) format and is available
for subscription at (Risk Group Website, iTunes, Google Play, Stitcher Radio, Android, and Risk Group Professional Social Media).
About Risk Group
Risk Group LLC is a leading strategic
security risk analytics platform.
Copyright Risk Group LLC. All
Rights Reserved
The post Biobanking Trends appeared first on Risk Group.
View all episodes
By Risk Group
4
44 ratings
Dr. K. Stephen Suh, a Precision Medicine Expert, based in the United States, participates in Risk Roundup to discuss BioBanking Trends.
Risk Roundup Webcast: Biobanking Trends
Biobanking Trends
Technology has now made it possible for broad sharing of information, rapid analysis, and automation of testing. Moreover, the whole genome data and digital sharing capability are improving the research capabilities. From artificial intelligence-driven process automation, genetic testing, genome analysis, digitization, robotics, data analytics to the internet, the rapidly emerging technological advances, are on their way to revolutionizing biobanks, biorepository, and biospecimen science.
While drug discovery and development seems to be the primary focus, biobank research hopes to provide a new understanding into the genetic component of the disease, that would ultimately lead to a more personalized and precise approach to healthcare. Moreover, the growing investments are enabling the scientific progress that will strongly influence our knowledge about human health and disease, the quality and nature of health care, and human life.
Understandably, biobanking
is rapidly becoming a key area for infrastructure development as there is a
rise in many kinds of biobanks. From disease-centric, population-based, genetic
or DNA/RNA, project-driven, tissue versus multiple specimen types, commercial
versus community-based, microbiome to stem cells, and virtual biobanks, there
are many types of biobanks emerging. As the ultimate aims of biobanks include
promoting the health and well-being of the community at no individual cost or
risk, the question is, how will that be possible.
Complex Challenges
Biobanks have triggered a robust debate about ethical, legal, and social implications surrounding human samples and data due to issues of consent, privacy, confidentiality, and integrity of the samples and the return of results and data-sharing. So, as we witness the evolution of biobanking from a simple collection of frozen specimens to the virtual biobanks and bioscience as seen today, it is essential to understand its risks and rewards-
- What are the challenges
of biobanking broadly?Do all nations have
biobanks and the technology necessary for them?How will personalized
medicine benefit from biobanking?Are there any
guidelines about biobanking? What are the best practices?How can biobanks balance
benefits and risks?Is there a need for
regulation?
As biobanking is on its way to changing the world, the time is now to discuss the risks and rewards of biobanking.
For more, please watch the Risk Roundup Webcast or hear the Risk Roundup Podcast
About
the Guest
Dr. K. Stephen Suh is a professional with a Doctor of Philosophy (Ph.D.) focused in Cell and Molecular Biology, Animal Modeling of Cancer, 3-Dimensional Cell Culture and Tissue Engineering, and the use of Artificial Intelligence System on Data Mining of Electronic Health Records and Biobank-Patient Samples. He is an expert for Precision Medicine topics and achieving the concept for Personalized Medicine and biomarker-based Population and Patient Selection for clinical testing platforms.
About the Host of Risk Roundup
Jayshree
Pandya (née Bhatt), the founder and chief executive officer of Risk Group LLC (www.riskgroupllc.com) is working
passionately to define a new security-centric operating system for humanity.
Her efforts towards building a strategic security risk analytics platform are
to equip the global strategic security community with the tools and culture to
collectively imagine the strategic security risks to our future and to define
and design a new security-centric operating system for the future of humanity.
About Risk Roundup
Risk Roundup, a global initiative
launched by Risk Group, is a security risk reporting for risks emerging from
existing and emerging technologies, technology convergence, and transformation
happening across cyberspace, aquaspace, geospace, and space. Risk Roundup is
released in both audio (Podcast) and video (Webcast) format and is available
for subscription at (Risk Group Website, iTunes, Google Play, Stitcher Radio, Android, and Risk Group Professional Social Media).
About Risk Group
Risk Group LLC is a leading strategic
security risk analytics platform.
Copyright Risk Group LLC. All
Rights Reserved
The post Biobanking Trends appeared first on Risk Group.